Phaseline

Companies › Oticara Australia

Oticara Australia: clinical trials, targets and expected readouts

1 active drug program in 11 registered trials: 8 Phase 4, 2 Phase 3, 1 Phase 2; Neurology, Infectious disease, Oncology, Other.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Betamethasone
Glucocorticoid receptor agonist
NR3C1Phase 2Chronic Rhinosinusitis (Diagnosis); Hemiplegia; Myofascial Pain Dysfunction Syndrome; Anaphylactic Reaction …–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT05260125BetamethasonePhase 4HemiplegiaNeurologyMar 2025
NCT05882903BetamethasonePhase 2Chronic Rhinosinusitis (Diagnosis)RespiratoryJun 2025
NCT06915857BetamethasonePhase 3Breast CancerOncologyDec 2026
NCT07547605BetamethasonePhase 4Myofascial Pain Dysfunction SyndromeOtherDec 2026
NCT07341776BetamethasonePhase 4Anaphylactic ReactionOtherDec 2026
NCT05114096BetamethasonePhase 4Preterm BirthOtherDec 2026
NCT07508124BetamethasonePhase 4Urinary Tract InfectionInfectious diseaseDec 2027
NCT07692516BetamethasonePhase 4Subacromial Impingement SyndromeNeurologyDec 2027
NCT06527235BetamethasonePhase 3Meniscus LesionOtherJun 2028
NCT07416916BetamethasonePhase 4Frozen ShoulderOtherOct 2030
NCT07416916BetamethasonePhase 4Frozen ShoulderOtherOct 2030

Targets

NR3C1 (1)

Companies with the same targets

Corcept Therapeutics AstraZeneca Eupraxia Pharmaceuticals Alimera Sciences Laboratorios Sophia S.A de C.V. Optinose US Santhera Pharmaceuticals Pop Test Oncology Pacira Pharmaceuticals Tiohundra

Companies built like this

Optinose US Santhera Pharmaceuticals Corcept Therapeutics Alimera Sciences Guangzhou Novaken Pharm

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.